📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP). (2018)

First Author: Seddon JA

Attributed to: Correlates of risk in children exposed to multidrug-resistant tuberculosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-018-3070-0

PubMed Identifier: 30572905

Publication URI: http://europepmc.org/abstract/MED/30572905

Type: Journal Article/Review

Volume: 19

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215